Member of the Board of Directors, b. 1966

Education

M.Sc. (Chemistry/Biochemistry), Ph.D. (Biology/Immunology), General Management Program (European Centre for Executive Development, CEDEP)

Member since

2022

Nationality

German

Special competencies

Idea-to-Revenue executive management and board member creating health care value through In Vitro Diagnostics clinical and technology innovation. 25+ years of industry, global leadership and product development experience with large, public and mid-sized, private companies. Passionate about turning science and technology into solutions that make a difference for patients, clinicians and laboratories.

Career

• 2021- Chief Technology Officer and global Head of R&D and PMO, member of the Executive Management team, AliveDx, Switzerland
• 2020-2021 Global Head and Sr. Director for Clinical Diagnostic Division R&D and PMO, Thermo Fisher Scientific, Germany
• 2016-2021 Global Head and Sr. Director for BRAHMS Biomarker Business Unit R&D, Thermo Fisher Scientific, Germany
• 2010-2016 Global Head and VP of Immunoassay R&D, member of the clinical business unit management team, bioMerieux, France
• 2003-2010 Head of R&D Center and Director of R&D and Project Management, Abbott Diagnostics Division, Germany
• 1997-2003 Technical and management roles in Manufacturing Operations, Abbott Diagnostics Division, Germany

Other current or former key positions of trust

• 2022- Non-Executive Director and Board Member, Aidian, Finland
• 2019-2021 Healthcare jury member, Berlin-Brandenburg region innovation award
• 2018-2021 Member of the Test Evaluation working group, European Federation of Laboratory Medicine